Etiele de Senna Silveira

Dr. Etiele de Senna Silveira

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
Joel Henrique EllwangerJoel Henrique Ellwanger
Joel Henrique Ellwanger
PFPhilip Martin Fearnside
Philip Martin Fearnside
MZMarina Ziliotto
Marina Ziliotto
JVJacqueline Valverde Villegas
Jacqueline Valverde Villegas
AVAna B. Gorini da Veiga
Ana B. Gorini da Veiga
José Artur Bogo ChiesJosé Artur Bogo Chies
José Artur Bogo Chies
Zoonotic spillover is a phenomenon characterized by the transfer of pathogens between different animal species. Most human emerging infectious diseases originate from non-human animals, and human-related environmental disturbances are the driving forces of the emergence of new human pathogens. Synthesizing the sequence of basic events involved in the emergence of new human pathogens is important for guiding the understanding, identification, and description of key aspects of human activities that can be changed to prevent new outbreaks, epidemics, and pandemics. This review synthesizes the connections between environmental disturbances and increased risk of spillover events based on the One Health perspective. Anthropogenic disturbances in the environment (e.g., deforestation, habitat fragmentation, biodiversity loss, wildlife exploitation) lead to changes in ecological niches, reduction of the dilution effect, increased contact between humans and other animals, changes in the incidence and load of pathogens in animal populations, and alterations in the abiotic factors of landscapes. These phenomena can increase the risk of spillover events and, potentially, facilitate new infectious disease outbreaks. Using Brazil as a study model, this review brings a discussion concerning anthropogenic activities in the Amazon region and their potential impacts on spillover risk and spread of emerging diseases in this region.

13 July 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
ASAline Miranda Scovino
Aline Miranda Scovino
EDElizabeth Chen Dahab
Elizabeth Chen Dahab
Israel Diniz-LimaIsrael Diniz-Lima
Israel Diniz-Lima
ESEtiele de Senna Silveira
Etiele de Senna Silveira
SBShana Barroso
Shana Barroso
AMAlexandre Morrot
Alexandre Morrot
Since the first description of SARS-CoV-2 in China in 2019, thousands of variants have emerged worldwide. For some of them, the constellation of mutations caused changes in virus biology, pathogenicity, infectivityity and transmissibility resulting in dissemination throughout the world. Gamma variant (P.1) differs from SARS-CoV-2 Wuhan strain (B.1) by 12 amino acids in the Spike (S) protein, and presented mutations related to greater affinity for the receptor angioten-sin-converting enzyme 2 (ACE-2) and/or immune escape. The Gamma variant and subvariants were responsible for the second wave of COVID-19 in the Brazilian city of Manaus, characterized by high mortality and rapid transmission. The ability of variants to induce cytokine production may be closely related to their pathogenicity. Herein we observed that there was no significant difference in the quantity of cytokines among macrophages or neutrophils infected with P.1 and B.1 strains. Also, no significant difference was observed in the absolute number of macrophages and neutrophils infected with these variants. Furthermore, no evidence of SARS-CoV-2 replication was observed in macrophages when infected by the two analyzed variants. Our findings suggest that the difference in the epidemiological outcome observed during the P.1 variant spread when compared to B.1, it is not explained by differences in the quantity of cytokines and absolute number of macrophages or neutrophils. Through bioinformatics analysis of the S protein, we observed that the physicochemical differences between the variants and subvariants of P.1, probably refer to the degree of infectivity, due to the impact caused in the recognition of antibodies and receptor af-finity

2 April 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
ASAline Miranda Scovino
Aline Miranda Scovino
EDElizabeth Chen Dahab
Elizabeth Chen Dahab
Israel Diniz-LimaIsrael Diniz-Lima
Israel Diniz-Lima
ESEtiele de Senna Silveira
Etiele de Senna Silveira
SBShana Barroso
Shana Barroso
AMAlexandre Morrot
Alexandre Morrot
The SARS-CoV-2 P.1 variant, responsible for an outbreak in Manaus, Brazil, is distinguished by 12 amino acid differences in the S protein, potentially increasing its ACE-2 affinity and immune evasion capability. We investigated the innate immune response of this variant compared to the original B.1 strain, particularly concerning cytokine production. Blood samples from three severe COVID-19 patients were analyzed post-infection with both strains. Results showed no significant difference in cytokine production of mononuclear cells and neutrophils for either variant. While B.1 had higher cytopathogenicity, neither showed viral replication in mononuclear cells. Structural analyses of the S protein highlighted physicochemical variations, which might be linked to the differences in infectivity between the strains. Our studies point to the increased infectivity of P.1 could stem from altered immunogenicity and receptor-binding affinity.

12 September 2025 in bioRxiv
Verified
Preprint
Open access
ESEtiele de Senna Silveira
Etiele de Senna Silveira
BVBruna Bordignon Vian
Bruna Bordignon Vian
EAEduardo Cheuiche Antonio
Eduardo Cheuiche Antonio
RTRenata Fioravanti Tarabini
Renata Fioravanti Tarabini
GVGustavo Fioravanti Vieira
Gustavo Fioravanti Vieira
The ability of T cells to discriminate self from non-self peptides is a cornerstone of adaptive immunity, yet the structural principles guiding this process remain poorly defined. Here, we present a proof-of-concept study using physicochemical descriptors derived from images of peptide-MHC (pMHC) surfaces to explore patterns of immunogenicity. We modeled 353 pMHC complexes restricted to HLA-A*02:01, comprising 106 self-derived peptides from the HLA Ligand Atlas and 247 viral epitopes from the Immune Epitope Database. Electrostatic potentials of TCR-facing interfaces were computed and transformed into quantitative features across 92 immunologically relevant regions of interest. Unsupervised hierarchical clustering uncovered subsets of pMHCs forming self-only, viral-only, and mixed clusters, revealing conserved structural fingerprints linked to tolerance or immunogenicity. Heatmap analysis identified close viral-self proximities, highlighting candidate pairs potentially involved in molecular mimicry and autoimmune triggers. Building on these findings, we trained an XGBoost classifier that achieved strong performance (F1 score 0.87; AUC 0.84) in distinguishing self from viral peptides. To our knowledge, this is the first demonstration that structural and physicochemical fingerprints of pMHC complexes are sufficient to discriminate self from non-self. These results establish a framework for computational immunology and provide hypotheses for validation, with implications for autoimmunity, vaccine design, and immunotherapy.